MC
Mangesh Chandrakant Karwa
About Mangesh Chandrakant Karwa
Data last updated:
Mangesh Chandrakant Karwa is a Director at Sinhagad Pharma Private Limited (since 2020), Partner at Cardio123 Llp (since 2024) and Designated Partner at Citycare Pharmacy Llp (since 2022). The companies operate in Pharma and Metal & Minerals. The largest current company by reported revenue is Sinhagad Pharma Private Limited at ₹10.77 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 25 Aug 2020 | 2020 | ₹10.77 Cr (FY 2025) | Active | |
| Partner | 30 Apr 2024 | 2023 | Active | ||
| Designated Partner | 13 Jun 2022 | 2022 | Active |
Board colleagues of Mangesh Chandrakant Karwa
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mangesh Chandrakant Karwa
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mangesh Chandrakant Karwa
Mangesh Chandrakant Karwa currently holds 3 directorships: Sinhagad Pharma Private Limited (Director, since 25 Aug 2020, revenue ₹10.77 Cr (FY 2025)); Cardio123 Llp (Partner, since 30 Apr 2024); Citycare Pharmacy Llp (Designated Partner, since 13 Jun 2022).
Mangesh Chandrakant Karwa was first appointed on 25 Aug 2020 as Director at Sinhagad Pharma Private Limited. The most recent appointment on record is 30 Apr 2024 at Cardio123 Llp.
The current boards of Mangesh Chandrakant Karwa's companies include Ajit Ambadas Borhade (Sinhagad Pharma Private Limited), Ashok Ramchandra Navadkar (Sinhagad Pharma Private Limited), Chetan Rajendra Sharma (Sinhagad Pharma Private Limited), Dhananjay Madhav Bapat (Sinhagad Pharma Private Limited), Kishor Devidas Bagad (Sinhagad Pharma Private Limited), Mohan Jaysing Deshmukh (Sinhagad Pharma Private Limited), among others.